Bile acid signaling is involved in the neurological decline in a murine model of acute liver failure

American Journal of Pathology

Volumn 186, Issue 2, 2016, Pages 312-323

  McMillin, Matthew ^a,b,c   Frampton, Gabriel ^a,b,c   Quinn, Matthew ^a,d   Ashfaq, Samir ^b   De Los Santos, Mario ^b   Grant, Stephanie ^a,b,c   DeMorrow, Sharon ^a,b,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; COLESTYRAMINE; DEOXYCHOLIC ACID; FARNESOID X RECEPTOR; COTRANSPORTER; CYP7A1 PROTEIN, MOUSE; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER;

ACUTE LIVER FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEEDING; HEPATIC ENCEPHALOPATHY; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BLOOD BRAIN BARRIER; C57BL MOUSE; CENTRAL NERVOUS SYSTEM DISEASES; COMPLICATION; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BILE ACIDS AND SALTS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLIC ACID; DISEASE MODELS, ANIMAL; LIVER FAILURE, ACUTE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; SIGNAL TRANSDUCTION; SYMPORTERS;

EID: 84955264038     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.10.005     Document Type: Article

References (58)

1. R.F. Butterworth Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53 2011 1372 1376
2. A.S. Hazell, and R.F. Butterworth Hepatic encephalopathy: an update of pathophysiologic mechanisms Proc Soc Exp Biol Med 222 1999 99 112
3. L. Kramer, and K. Kodras Detoxification as a treatment goal in hepatic failure Liver Int 31 Suppl 3 2011 1 4
4. G. Ostapowicz, R.J. Fontana, F.V. Schiodt, A. Larson, T.J. Davern, S.H. Han, T.M. McCashland, A.O. Shakil, J.E. Hay, L. Hynan, J.S. Crippin, A.T. Blei, G. Samuel, J. Reisch, and W.M. Lee Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947 954
5. M.V. St-Pierre, G.A. Kullak-Ublick, B. Hagenbuch, and P.J. Meier Transport of bile acids in hepatic and non-hepatic tissues J Exp Biol 204 2001 1673 1686
6. P.A. Dawson Role of the intestinal bile acid transporters in bile acid and drug disposition Handb Exp Pharmacol 201 2011 169 203
7. R.N. Redinger The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: bile salts as ligands for nuclear hormone receptors Can J Gastroenterol 17 2003 265 271
8. G. Rizzo, B. Renga, A. Mencarelli, R. Pellicciari, and S. Fiorucci Role of FXR in regulating bile acid homeostasis and relevance for human diseases Curr Drug Targets Immune Endocr Metabol Disord 5 2005 289 303
9. H. Greim, D. Trulzsch, P. Czygan, J. Rudick, F. Hutterer, F. Schaffner, and H. Popper Mechanism of cholestasis, 6: bile acids in human livers with or without biliary obstruction Gastroenterology 63 1972 846 850
10. H. Greim, D. Trulzsch, J. Roboz, K. Dressler, P. Czygan, F. Hutterer, F. Schaffner, and H. Popper Mechanism of cholestasis, 5: bile acids in normal rat livers and in those after bile duct ligation Gastroenterology 63 1972 837 845
11. P. Muriel, and V. Castro Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats Pharmacology 54 1997 179 185
12. D.S. Raiford Pruritus of chronic cholestasis QJM 88 1995 603 607
13. Z. Ma, S.S. Lee, and J.B. Meddings Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy J Hepatol 26 1997 904 912
14. A. Bomzon, and P. Ljubuncic Bile acids as endogenous vasodilators? Biochem Pharmacol 49 1995 581 589
15. B.L. Shneider, P.A. Dawson, D.M. Christie, W. Hardikar, M.H. Wong, and F.J. Suchy Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter J Clin Invest 95 1995 745 754
16. S.K. Erickson, S.R. Lear, S. Deane, S. Dubrac, S.L. Huling, L. Nguyen, J.S. Bollineni, S. Shefer, H. Hyogo, D.E. Cohen, B. Shneider, E. Sehayek, M. Ananthanarayanan, N. Balasubramaniyan, F.J. Suchy, A.K. Batta, and G. Salen Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice J Lipid Res 44 2003 1001 1009
17. M. McMillin, C. Galindo, H.Y. Pae, G. Frampton, P. Di Patre, M. Quinn, E. Whittington, and S. DeMorrow Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice J Hepatol 61 2014 1260 1266
18. M. McMillin, G. Frampton, M. Thompson, C. Galindo, H. Standeford, E. Whittington, G. Alpini, and S. DeMorrow Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline J Neuroinflammation 11 2014 121
19. M. McMillin, G. Frampton, R. Tobin, G. Dusio, J. Smith, H. Shin, M.K. Newell-Rogers, S. Grant, and S. DeMorrow TGR5 signaling reduces neuroinflammation during hepatic encephalopathy J Neurochem 135 2015 565 576
20. M.K. Baskaya, A. Dogan, A.M. Rao, and R.J. Dempsey Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury J Neurosurg 92 2000 448 452
21. C. Cao, X. Yu, Z. Liao, N. Zhu, H. Huo, M. Wang, G. Ji, H. She, Z. Luo, and S. Yue Hypertonic saline reduces lipopolysaccharide-induced mouse brain edema through inhibiting aquaporin 4 expression Crit Care 16 2012 R186
22. C. Bemeur, J. Vaquero, P. Desjardins, and R.F. Butterworth N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms Metab Brain Dis 25 2010 241 249
23. Y. Zhang, and C.D. Klaassen Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice J Lipid Res 51 2010 3230 3242
24. C.O. Mills, K. Rahman, R. Coleman, and E. Elias Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver Biochim Biophys Acta 1115 1991 151 156
25. D.R. de Waart, S. Hausler, M.L. Vlaming, C. Kunne, E. Hanggi, H.J. Gruss, R.P. Oude Elferink, and B. Stieger Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein J Pharmacol Exp Ther 334 2010 78 86
26. M. Quinn, M. McMillin, C. Galindo, G. Frampton, H.Y. Pae, and S. DeMorrow Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms Dig Liver Dis 46 2014 527 534
27. G. Frampton, M. Coufal, H. Li, J. Ramirez, and S. DeMorrow Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling Exp Cell Res 316 2010 1465 1478
28. S. DeMorrow, S. Glaser, H. Francis, J. Venter, B. Vaculin, S. Vaculin, and G. Alpini Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts J Biol Chem 282 2007 13098 13113
29. S. Goodenough, M. Davidson, W. Chen, A. Beckmann, Z. Pujic, M. Otsuki, I. Matsumoto, and P. Wilce Immediate early gene expression and delayed cell death in limbic areas of the rat brain after kainic acid treatment and recovery in the cold Exp Neurol 145 1997 451 461
30. G. Frampton, P. Invernizzi, F. Bernuzzi, H.Y. Pae, M. Quinn, D. Horvat, C. Galindo, L. Huang, M. McMillin, B. Cooper, L. Rimassa, and S. DeMorrow Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism Gut 61 2012 268 277
31. S. DeMorrow, H. Francis, E. Gaudio, J. Venter, A. Franchitto, S. Kopriva, P. Onori, R. Mancinelli, G. Frampton, M. Coufal, B. Mitchell, B. Vaculin, and G. Alpini The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway Am J Physiol Gastrointest Liver Physiol 295 2008 G1150 G1158
32. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
33. S. Goodenough, M. Davidson, G. Kidd, I. Matsumoto, and P. Wilce Cell death and immunohistochemistry of p53, c-Fos and c-Jun after spermine injection into the rat striatum Exp Brain Res 131 2000 126 134
34. W.J. Cash, P. McConville, E. McDermott, P.A. McCormick, M.E. Callender, and N.I. McDougall Current concepts in the assessment and treatment of hepatic encephalopathy QJM 103 2010 9 16
35. T. Hori, F. Chen, A.M. Baine, L.B. Gardner, and J.H. Nguyen Fulminant liver failure model with hepatic encephalopathy in the mouse Ann Gastroenterol 24 2011 294 306
36. A.R. Jayakumar, R. Ruiz-Cordero, X.Y. Tong, and M.D. Norenberg Brain edema in acute liver failure: role of neurosteroids Arch Biochem Biophys 536 2013 171 175
37. M.A. McMillin, G.A. Frampton, A.P. Seiwell, N.S. Patel, A.N. Jacobs, and S. DeMorrow TGFbeta1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5 Lab Invest 95 2015 903 913
38. J.H. Nguyen, S. Yamamoto, J. Steers, D. Sevlever, W. Lin, N. Shimojima, M. Castanedes-Casey, P. Genco, T. Golde, E. Richelson, D. Dickson, M. McKinney, and C.B. Eckman Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice J Hepatol 44 2006 1105 1114
39. A. Chastre, M. Belanger, B.N. Nguyen, and R.F. Butterworth Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure Liver Int 34 2014 353 361
40. R.F. Butterworth The liver-brain axis in liver failure: neuroinflammation and encephalopathy Nat Rev Gastroenterol Hepatol 10 2013 522 528
41. C. Bemeur, H. Qu, P. Desjardins, and R.F. Butterworth IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure Neurochem Int 56 2010 213 215
42. K.A. Matkowskyj, J.A. Marrero, R.E. Carroll, A.V. Danilkovich, R.M. Green, and R.V. Benya Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model Am J Physiol 277 1999 G455 G462
43. G. Kakiyama, W.M. Pandak, P.M. Gillevet, P.B. Hylemon, D.M. Heuman, K. Daita, H. Takei, A. Muto, H. Nittono, J.M. Ridlon, M.B. White, N.A. Noble, P. Monteith, M. Fuchs, L.R. Thacker, M. Sikaroodi, and J.S. Bajaj Modulation of the fecal bile acid profile by gut microbiota in cirrhosis J Hepatol 58 2013 949 955
44. B. Bron, R. Waldram, D.B. Silk, and R. Williams Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure Gut 18 1977 692 696
45. V. Tripodi, M. Contin, M.A. Fernandez, and A. Lemberg Bile acids content in brain of common duct ligated rats Ann Hepatol 11 2012 930 934
46. J.M. Choi, Y.H. Kim, and S.Y. Roh Acute hepatic encephalopathy presenting as cortical laminar necrosis: case report Korean J Radiol 14 2013 324 328
47. S.M. Arnold, T. Els, J. Spreer, and M. Schumacher Acute hepatic encephalopathy with diffuse cortical lesions Neuroradiology 43 2001 551 554
48. E. Matsusue, T. Kinoshita, E. Ohama, and T. Ogawa Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations AJNR Am J Neuroradiol 26 2005 347 351
49. A.E. Kremer, U. Beuers, R.P. Oude-Elferink, and T. Pusl Pathogenesis and treatment of pruritus in cholestasis Drugs 68 2008 2163 2182
50. F. Scaldaferri, M. Pizzoferrato, F.R. Ponziani, G. Gasbarrini, and A. Gasbarrini Use and indications of cholestyramine and bile acid sequestrants Intern Emerg Med 8 2013 205 210
51. B. Bhushan, P. Borude, G. Edwards, C. Walesky, J. Cleveland, F. Li, X. Ma, and U. Apte Role of bile acids in liver injury and regeneration following acetaminophen overdose Am J Pathol 183 2013 1518 1526
52. S. Choudhuri, N.J. Cherrington, N. Li, and C.D. Klaassen Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats Drug Metab Dispos 31 2003 1337 1345
53. F. Chen, N. Ohashi, W. Li, C. Eckman, and J.H. Nguyen Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure Hepatology 50 2009 1914 1923
54. K. Faropoulos, E. Chroni, S.F. Assimakopoulos, A. Mavrakis, V. Stamatopoulou, C. Toumpeki, D. Drainas, K. Grintzalis, I. Papapostolou, C.D. Georgiou, and D. Konstantinou Altered occludin expression in brain capillaries induced by obstructive jaundice in rats Brain Res 1325 2010 121 127
55. N. Shimojima, C.B. Eckman, M. McKinney, D. Sevlever, S. Yamamoto, W. Lin, D.W. Dickson, and J.H. Nguyen Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure J Invest Surg 21 2008 101 108
56. G. Wright, N.A. Davies, D.L. Shawcross, S.J. Hodges, C. Zwingmann, H.F. Brooks, A.R. Mani, D. Harry, V. Stadlbauer, Z. Zou, R. Williams, C. Davies, K.P. Moore, and R. Jalan Endotoxemia produces coma and brain swelling in bile duct ligated rats Hepatology 45 2007 1517 1526
57. V. Keitel, B. Gorg, H.J. Bidmon, I. Zemtsova, L. Spomer, K. Zilles, and D. Haussinger The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain Glia 58 2010 1794 1805
58. M. Belanger, J. Cote, and R.F. Butterworth Neurobiological characterization of an azoxymethane mouse model of acute liver failure Neurochem Int 48 2006 434 440